Furthermore, a down-regulation of Specialized Proresolving Mediators (SPM) ALX/FPR2 and BLT1 receptors in peripheral blood CD14pos cells suggest a putative role of those receptors as biomarkers of inflammation resolution in RA [50]. This evidence concerns the gene FPR2 and rheumatoid arthritis.